Amino acid compositions

US10485777B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-10485777-B1
Application numberUS-201314065368-A
CountryUS
Kind codeB1
Filing dateOct 28, 2013
Priority dateSep 18, 2007
Publication dateNov 26, 2019
Grant dateNov 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition comprising a Nitrate or a Nitrite of an Amino Acid Compound selected from the group consisting of Arginine, Agmatine, Beta Alanine, Citrulline, Creatine, Glutamine, L-Histidine, Isoleucine, Leucine, Norvaline, Ornithine, Valine, Aspartic Acid, Cysteine, Glycine, Lysine, Methionine, Proline, Tyrosine, and Phenylalanine is provided. The composition may be in a dosage form selected from the group consisting of a capsule, a cachet, a pill, a tablet, a powder, a granule, a pellet, a bead, a particle, a troche, a lozenge, a gel, a liquid, a suspension, a solution, an elixir, and a syrup.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition for human ingestion comprising a nitrate of a compound selected from the group consisting of agmatine, citrulline, and norvaline, wherein the nitrate of the compound is a salt of a nitric acid (NO 3 − ) or a mixed salt of a nitric acid (NO 3 − ) and is a solid at standard ambient temperature and pressure. 2. The composition of claim 1 , wherein the compound is agmatine. 3. The composition of claim 1 , wherein compound is citrulline. 4. The composition of claim 1 , wherein the compound is norvaline. 5. The composition of claim 1 , wherein the composition is in a dosage form selected from the group consisting of a capsule, a cachet, a pill, a tablet, a powder, a granule, a pellet, a bead, a particle, a troche, and a lozenge. 6. The composition of claim 1 , further comprising one or more additional components selected from the group consisting of a carrier, an excipient, a binder, a colorant, a flavoring agent, a preservative, a buffer, a dilutant, and any combination thereof. 7. A composition for human ingestion comprising: a nitrate of a compound selected from the group consisting of agmatine, beta alanine, citrulline, creatine, glutamine, isoleucine, norvaline, ornithine, aspartic acid, cysteine, glycine, lysine, proline, tyrosine, and phenylalanine, wherein the nitrate of a compound is a salt of a nitric acid (NO 3 − ) or a mixed salt of a nitric acid (NO 3 − ), and one or more additional components selected from the group consisting of a carrier, an excipient, a binder, a colorant, a flavoring agent, a preservative, a buffer, and a dilutant. 8. The composition of claim 7 , wherein the one or more additional components is a carrier, an excipient, a binder, or a flavoring agent. 9. The composition of claim 1 , wherein the composition is a human dietary supplement. 10. The composition of claim 7 , wherein the composition is a human dietary supplement. 11. The composition of claim 5 , wherein the dosage form is a capsule. 12. The composition of claim 5 , wherein the dosage form is a cachet. 13. The composition of claim 5 , wherein the dosage form is a pill. 14. The composition of claim 5 , wherein the dosage form is a tablet. 15. The composition of claim 5 , wherein the dosage form is a powder. 16. The composition of claim 5 , wherein the dosage form is a granule. 17. The composition of claim 5 , wherein the dosage form is a pellet. 18. The composition of claim 5 , wherein the dosage form is a bead. 19. The composition of claim 5 , wherein the dosage form is a particle. 20. The composition of claim 5 , wherein the dosage form is a troche. 21. The composition of claim 5 , wherein the dosage form is a lozenge. 22. The composition of claim 1 , further comprising a carrier. 23. The composition of claim 1 , further comprising an excipient. 24. The composition of claim 1 , further comprising a binder. 25. The composition of claim 1 , further comprising a colorant. 26. The composition of claim 1 , further comprising a flavoring agent. 27. The composition of claim 1 , further comprising a preservative. 28. The composition of claim 1 , further comprising a buffer. 29. The composition of claim 1 , further comprising a dilutant. 30. The composition of claim 7 , wherein the one or more additional components is a carrier. 31. The composition of claim 7 , wherein the one or more additional components is an excipient. 32. The composition of claim 7 , wherein the one or more additional components is a binder. 33. The composition of claim 7 , wherein the one or more additional components is a colorant. 34. The composition of claim 7 , wherein the one or more additional components is a flavoring agent. 35. The composition of claim 7 , wherein the one or more additional components is a preservative. 36. The composition of claim 7 , wherein the one or more additional components is a buffer. 37. The composition of claim 7 , wherein the one or more additional components is a dilutant. 38. The composition of claim 7 comprising the nitrate of agmatine. 39. The composition of claim 7 comprising the nitrate of beta alanine. 40. The composition of claim 7 comprising the nitrate of citrulline. 41. The composition of claim 7 comprising the nitrate of creatine. 42. The composition of claim 7 comprising the nitrate of glutamine. 43. The composition of claim 7 comprising the nitrate of isoleucine. 44. The composition of claim 7 comprising the nitrate of norvaline. 45. The composition of claim 7 comprising the nitrate of ornithine. 46. The composition of claim 7 comprising the nitrate of aspartic acid. 47. The composition of claim 7 comprising the nitrate of cysteine. 48. The composition of claim 7 comprising the nitrate of glycine. 49. The composition of claim 7 comprising the nitrate of lysine. 50. The composition of claim 7 comprising the nitrate of proline. 51. The composition of claim 7 comprising the nitrate of tyrosine. 52. The composition of claim 7 comprising the nitrate of phenylalanine. 53. The composition of claim 7 , wherein the nitrate of the compound is the nitrate of creatine and the one or more additional component is an excipient. 54. The composition of claim 7 , wherein the nitrate of the compound is the nitrate of creatine and the one or more additional component is a flavoring agent. 55. The composition of claim 7 , wherein the nitrate of the compound is the nitrate of creatine and the one or more additional component is a colorant.

Assignees

Inventors

Classifications

  • Drugs for disorders of the muscular or neuromuscular system · CPC title

  • A61K31/198Primary

    Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00) · CPC title

  • Imidazole-alkanecarboxylic acids, e.g. histidine · CPC title

  • Proline; Derivatives thereof, e.g. captopril · CPC title

  • having more than one amino group bound to the carbon skeleton, e.g. lysine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10485777B1 cover?
A composition comprising a Nitrate or a Nitrite of an Amino Acid Compound selected from the group consisting of Arginine, Agmatine, Beta Alanine, Citrulline, Creatine, Glutamine, L-Histidine, Isoleucine, Leucine, Norvaline, Ornithine, Valine, Aspartic Acid, Cysteine, Glycine, Lysine, Methionine, Proline, Tyrosine, and Phenylalanine is provided. The composition may be in a dosage form selected f…
Who is the assignee on this patent?
Thermolife Int Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/198. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).